This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Coadministration of Isoniazid and Antidepressant Drugs

Parviz Malek-Ahmadi, MD; Marina Chavez, MD; and Salvador A. Contreras, MD

Published: November 15, 1996

Article Abstract

Letter to the Editor

Sir: Isonicotinylhydrazide, also known as isoniazid, is awell-known agent for treatment of mycobacterial infections. Itis also used for prevention of tuberculosis, given 300 mg/dayfor a period of at least 6 months. In vivo studies, usingbenzylamine as substrate, have demonstrated that isoniazid intherapeutic doses inhibits plasma monoamine oxidase (MAO)with no significant effect on platelet MAO.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 57

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Frontothalamic Circuit Abnormalities in Patients With Bipolar Depression and Suicide Attempts

To identify potential markers for suicide risk, this fMRI study looked at neural activity in bipolar depression...

Read More...